Impact of trial eligibility criteria on enrollment to KRASG12C inhibitor trials in patients with non-small cell lung cancer.

被引：0
|
作者：
May, Michael S.
Wooster, Margaux
May, Benjamin
Shu, Catherine A.
Henick, Brian S.
Stoopler, Mark
Smith-Marrone, Stephanie
Saqi, Anjali
Mansukhani, Mahesh M.
Riely, Gregory J.
Hershman, Dawn L.
Herzberg, Benjamin
机构：
[1] Columbia Univ Med Ctr, New York, NY USA
[2] Columbia Univ, Herbert Irving Comprehens Canc Ctr, Med Ctr, New York, NY USA
[3] Columbia Univ, Irving Med Ctr, New York, NY USA
[4] NYP Columbia, Bronxville, NY USA
[5] Columbia Univ, New York, NY USA
[6] Mem Sloan Kettering Canc Ctr, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11012
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Rapid autopsy provides unique research opportunity to evaluate KRASG12C inhibitor resistance mechanisms in non-small cell lung cancer
    Ozakinci, Hilal
    Nazario, Gina
    Stern, Yaakov
    Solanki, Hitendra S.
    Chen, Dung-Tsa
    Trevor, Rose
    Schabath, Matthew
    Stewart, Paul
    Teer, Jamie K.
    Beg, Amer
    Boyle, Theresa A.
    Haura, Eric
    Pellini, Bruna
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [22] KRASG12C Inhibitor as a Treatment Option for Non-Small-Cell Lung Cancer with Comorbid Interstitial Pneumonia
    Fujimoto, Kazushi
    Ikeda, Satoshi
    Tabata, Erina
    Kaneko, Taichi
    Sagawa, Shinobu
    Yamada, Chieri
    Kumagai, Kosumi
    Fukushima, Takashi
    Haga, Sanshiro
    Watanabe, Masayuki
    Muraoka, Tatsuya
    Sekine, Akimasa
    Baba, Tomohisa
    Ogura, Takashi
    CANCERS, 2024, 16 (07)
  • [23] Therapeutic activity of a new KRASG12C inhibitor JMKX001899 in brain metastases: Preclinical models of KRASG12C-mutant non-small cell lung cancer
    He, Danming
    Wang, Jie
    Zhu, Yixiang
    Zhong, Jia
    Bai, Hua
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [24] Weight loss affects outcome in KrasG12C non-small cell lung cancer first line treated patients.
    Fancelli, Sara
    Caliman, Enrico
    Pillozzi, Serena
    Napolitano, Brunella
    Pieroni, Edoardo
    Mazzoni, Francesca
    Paglialunga, Luca
    Michelet, Marta Rita Gatta
    Roviello, Giandomenico
    Castiglione, Francesca
    Bartoli, Caterina
    Antonuzzo, Lorenzo
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [25] CRISPR Screening Identifies Mechanisms of Resistance to KRASG12C and SHP2 Inhibitor Combinations in Non-Small Cell Lung Cancer
    Prahallad, Anirudh
    Weiss, Andreas
    Voshol, Hans
    Kerr, Grainne
    Sprouffske, Kathleen
    Yuan, Tina
    Ruddy, David
    Meistertzheim, Morgane
    Kazic-Legueux, Malika
    Kottarathil, Tina
    Piquet, Michelle
    Cao, Yichen
    Martinuzzi-Duboc, Laetitia
    Buhles, Alexandra
    Adler, Flavia
    Mannino, Salvatore
    Tordella, Luca
    Sansregret, Laurent
    Maira, Sauveur-Michel
    Graus Porta, Diana
    Fedele, Carmine
    Brachmann, Saskia M.
    CANCER RESEARCH, 2023, 83 (24) : 4130 - 4141
  • [26] Gene expression correlates of adagrasib response in KRASG12C mutated non-small cell lung cancer (NSCLC)
    Kim, Eejung
    Tong, Xinyuan
    Patel, Ayushi
    Liu, Shengwu
    Dilly, Julien
    Hover, Laura
    Mukhopadhyay, Suman
    Sherman, Fiona
    Christensen, James G.
    Olson, Peter
    Aguirre, Andrew
    Wong, Kwok
    Ji, Hongbin
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [27] Influence of Brain Metastases on Survival of KRASG12C Mutated Stage IV Immune Checkpoint Inhibitor Treated Non-Small Cell Lung Cancer Patients
    Swart, E.
    Noordhof, A. L.
    Damhuis, R. A. M.
    Kunst, P. W. A.
    De Ruysscher, D. K. M.
    Hendriks, L. E. L.
    van Geffen, W. H.
    Aarts, M. J.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S349 - S349
  • [28] Combined inhibition of KRASG12C and mTORC1 kinase is synergistic in non-small cell lung cancer
    Kitai, Hidenori
    Choi, Philip H.
    Yang, Yu C.
    Boyer, Jacob A.
    Whaley, Adele
    Pancholi, Priya
    Thant, Claire
    Reiter, Jason
    Chen, Kevin
    Markov, Vladimir
    Taniguchi, Hirokazu
    Yamaguchi, Rui
    Ebi, Hiromichi
    Evans, James
    Jiang, Jingjing
    Lee, Bianca
    Wildes, David
    de Stanchina, Elisa
    Smith, Jacqueline A. M.
    Singh, Mallika
    Rosen, Neal
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [29] Proteomic and transcriptomic subtypes of KRASG12c mutant lung cancer.
    Solanki, Hitendra Singh
    Stewart, Paul A.
    Welsh, Eric A.
    Izumi, Victoria
    Fang, Bin
    Yoder, Sean J.
    Koomen, John M.
    Haura, Eric B.
    CANCER RESEARCH, 2022, 82 (12)
  • [30] Effect of sponsor on enrollment criteria in non-small cell lung cancer clinical trials
    Cooper, Ryan A.
    Chai, Yan
    Nieva, Jorge
    JOURNAL OF CANCER POLICY, 2022, 33
12345